atorvastatin has been researched along with Embolus in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calabria, P; Limbruno, U; Micheli, A; Picchi, A | 1 |
| Li, L; Liu, T; Liu, Y; Su, Q; Wang, J; Zhou, Y | 1 |
| Chen, H; Li, L; Liu, T; Su, Q; Wang, J; Wang, XT; Zhou, Y | 1 |
| Caselli, S; Celotto, A; Cohen, A; De Castro, S; Di Angelantonio, E; Fiorelli, M; Marcantonio, A; Pandian, N; Papetti, F; Passaseo, I | 1 |
| Di Sciascio, G; Nusca, A; Pasceri, V; Patti, G | 1 |
1 review(s) available for atorvastatin and Embolus
| Article | Year |
|---|---|
[Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
Topics: Actuarial Analysis; Adenosine; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Biomarkers; Clopidogrel; Creatine Kinase, MB Form; Electrocardiography; Embolism; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Randomized Controlled Trials as Topic; Risk Factors; Stents; Ticlopidine; Time Factors; Vasodilator Agents | 2005 |
4 other study(ies) available for atorvastatin and Embolus
| Article | Year |
|---|---|
[A multi-device approach to an unusual case of left main thrombosis: when manual thrombectomy is not enough].
Topics: Abciximab; Acute Coronary Syndrome; Antibodies, Monoclonal; Anticoagulants; Atorvastatin; Combined Modality Therapy; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Embolic Protection Devices; Embolism; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunoglobulin Fab Fragments; Infusions, Intra-Arterial; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Suction; Thrombectomy; Tomography, Optical Coherence | 2013 |
Effects of atorvastatin on PDCD4/NF-κB/TNF-α signaling pathway during coronary microembolization of miniature pigs.
Topics: Animals; Atorvastatin; Blotting, Western; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Embolism; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; NF-kappa B; Percutaneous Coronary Intervention; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Swine; Swine, Miniature; Tumor Necrosis Factor-alpha | 2015 |
Atorvastatin Inhibits Myocardial Apoptosis in a Swine Model of Coronary Microembolization by Regulating PTEN/PI3K/Akt Signaling Pathway.
Topics: Animals; Apoptosis; Atorvastatin; bcl-2-Associated X Protein; Caspase 3; Disease Models, Animal; Down-Regulation; Echocardiography; Embolism; Myocardial Infarction; Myocardium; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA Interference; RNA, Small Interfering; Signal Transduction; Swine; Troponin I | 2016 |
Short-term evolution (9 months) of aortic atheroma in patients with or without embolic events: a follow-up transoesophageal echocardiographic study.
Topics: Aged; Analysis of Variance; Anticoagulants; Aorta, Thoracic; Atherosclerosis; Atorvastatin; Confidence Intervals; Echocardiography, Transesophageal; Embolism; Female; Follow-Up Studies; Heptanoic Acids; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prospective Studies; Pyrroles; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |